Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Quest Diagnostics Inc. (NYSE:DGX)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Options | Financials
Location
One Malcolm Avenue
Teterboro, NJ 07608
Phone: (201) 393-5000
Fax: (201) 462-4169
Email: investor@questdiagnostics.com
Employees (last reported count): 25,000
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Website
 ·Home Page

 ·Search Yahoo! for related links...

Index Membership
 ·S&P 400 MidCap
Ownership
·Insider and 5%+ Owners: 61%
·Over the last 6 months:
 · 10 insider sells; 1.71M shares
  (2.9% of insider shares)
·Institutional: 57% (146% of float)
(549 institutions)
·Net Inst. Buying: 6.92M shares (+11.36%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Quest Diagnostics Incorporated is a provider of diagnostic testing and related services for the healthcare industry. The Company offers a broad range of clinical laboratory testing services used by physicians in the detection, diagnosis, evaluation, monitoring and treatment of diseases and other medical conditions. The Company is engaged in clinical laboratory testing and esoteric testing, including molecular diagnostics, as well as anatomic pathology services and testing for drugs of abuse. The Company has a network of principal laboratories located in approximately 30 metropolitan areas throughout the United States, several joint-venture laboratories and approximately 150 smaller rapid-response laboratories and 1,300 patient service centers. The Company also operates an esoteric testing laboratory and development facility, known as Nichols Institute, located in San Juan Capistrano, California, as well as laboratory facilities in Mexico City, Mexico and near London, England.
More from Market Guide: Expanded Business Description

Financial Summary
Quest Diagnostics is a clinical laboratory testing company which offers testing services used by the medical profession in the detection, diagnosis, monitoring and treatment of diseases. For the six months ended 6/30/01, net revenues increased 5% to $1.81 billion. Net income before extraordinary item rose 73% to $82.9 million. Revenues reflect improved pricing on manage care business and acquisitions. Earnings also benefitted from improved margins and lower interest expense.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY1999 Compensation
PayExer

Kenneth Freeman, 49
Chairman and CEO
$5.9M$197K
Surya Mohapatra, Ph.D., 50
Pres and COO
2.5M--  
Vijay Aggarwal, 50
Pres of Quest Diagnostics Ventures
--  --  
Robert Hagemann, 43
Corp. VP and CFO
1.0M--  
Joseph Manory
VP, Treasurer
--  --  
Dollar amounts are as of 31-Dec-1999 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year.
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NYSE:DGXAs of 31-Aug-2001
Price and Volume
52-Week Low
on 22-Mar-2001
$36.60 
Recent Price$62.65 
52-Week High
on 29-June-2001
$75.75 
Beta0.28 
Daily Volume (3-month avg)620.9K
Daily Volume (10-day avg)520.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y]
52-Week Change-2.8%
52-Week Change
relative to S&P500
+30.4%
Share-Related Items
Market Capitalization$5.94B
Shares Outstanding94.7M
Float36.9M
Dividends & Splits
Annual Dividendnone 
Last Split: 2 for 1 on 1-June-2001
Per-Share Data
Book Value (mrq)$12.28 
Earnings (ttm)$1.45 
Earnings (mrq)$0.48 
Sales (ttm)$36.28 
Cash (mrq)$1.84 
Valuation Ratios
Price/Book (mrq)5.10 
Price/Earnings (ttm)43.30 
Price/Sales (ttm)1.73 
Income Statements
Sales (ttm)$3.50B
EBITDA (ttm)$400.0M
Income available to common (ttm)$139.7M
Profitability
Profit Margin (ttm)4.0%
Operating Margin (ttm)7.4%
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)4.79%
Return on Equity (ttm)13.39%
Financial Strength
Current Ratio (mrq)1.07 
Debt/Equity (mrq)0.88 
Total Cash (mrq)$174.2M
Short Interest
As of 8-Aug-2001
Shares Short1.16M
Percent of Float3.1%
Shares Short
(Prior Month)
1.64M
Short Ratio1.73 
Daily Volume671.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   B = billions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.